Literature DB >> 17941623

Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.

Janice L Hyatt1, Randy M Wadkins, Lyudmila Tsurkan, Latorya D Hicks, M Jason Hatfield, Carol C Edwards, Charles R Ross, Stephanie A Cantalupo, Guy Crundwell, Mary K Danks, R Kip Guy, Philip M Potter.   

Abstract

Carboxylesterases (CE) are ubiquitous enzymes responsible for the detoxification of xenobiotics, including numerous clinically used drugs. Therefore, the selective inhibition of these proteins may prove useful in modulating drug half-life and bioavailability. Recently, we identified 1,2-diones as potent inhibitors of CEs, although little selectivity was observed in the inhibition of either human liver CE (hCE1) or human intestinal CE (hiCE). In this paper, we have further examined the inhibitory properties of ethane-1,2-diones toward these proteins and determined that, when the carbonyl oxygen atoms are cis-coplanar, the compounds demonstrate specificity for hCE1. Conversely, when the dione oxygen atoms are not planar (or are trans-coplanar), the compounds are more potent at hiCE inhibition. These properties have been validated in over 40 1,2-diones that demonstrate inhibitory activity toward at least one of these enzymes. Statistical analysis of the results confirms the correlation (P < 0.001) between the dione dihedral angle and the preferential inhibition of either hiCE or hCE1. Overall, the results presented here define the parameters necessary for small molecule inhibition of human CEs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941623     DOI: 10.1021/jm0706867

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.

Authors:  M J Hatfield; L Tsurkan; J L Hyatt; X Yu; C C Edwards; L D Hicks; R M Wadkins; P M Potter
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Authors:  Shuqi Xie; Abdolsamad Borazjani; M Jason Hatfield; Carol C Edwards; Philip M Potter; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

Review 3.  Carboxylesterase inhibitors.

Authors:  M Jason Hatfield; Philip M Potter
Journal:  Expert Opin Ther Pat       Date:  2011-05-24       Impact factor: 6.674

4.  Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

Authors:  Elizabeth I Parkinson; M Jason Hatfield; Lyudmila Tsurkan; Janice L Hyatt; Carol C Edwards; Latorya D Hicks; Bing Yan; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2011-07-04       Impact factor: 3.641

5.  The effect of hydrogen bonding on the conformations of 2-(1H-indol-3-yl)-2-oxoacetamide and 2-(1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide.

Authors:  Vijayakumar N Sonar; Sean Parkin; Peter A Crooks
Journal:  Acta Crystallogr C       Date:  2012-09-13       Impact factor: 1.172

Review 6.  Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.

Authors:  Upendra A Argikar; Philip M Potter; J Matthew Hutzler; Punit H Marathe
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

7.  Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.

Authors:  Sugunadevi Sakkiah; Keun Woo Lee
Journal:  Acta Pharmacol Sin       Date:  2012-06-11       Impact factor: 6.150

8.  In Silico Design and Evaluation of Carboxylesterase Inhibitors.

Authors:  Shana V Stoddard; Xiaozhen Yu; Philip M Potter; Randy M Wadkins
Journal:  J Pest Sci (2004)       Date:  2010       Impact factor: 5.918

9.  Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Lyudmila G Tsurkan; Janice L Hyatt; Carol C Edwards; Andrew Lemoff; Cynthia Jeffries; Bing Yan; Philip M Potter
Journal:  J Nat Prod       Date:  2013-01-03       Impact factor: 4.050

10.  Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

Authors:  Latorya D Hicks; Janice L Hyatt; Shana Stoddard; Lyudmila Tsurkan; Carol C Edwards; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.